SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 81 filers reported holding SYROS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $132,000 | +36.1% | 136,939 | +66.3% | 0.00% | – |
| Q1 2022 | $97,000 | -95.0% | 82,354 | -76.8% | 0.00% | -100.0% |
| Q2 2021 | $1,932,000 | +1433.3% | 354,453 | +2942.0% | 0.01% | – |
| Q4 2020 | $126,000 | +207.3% | 11,652 | +148.7% | 0.00% | – |
| Q3 2020 | $41,000 | -93.1% | 4,686 | -91.6% | 0.00% | -100.0% |
| Q2 2020 | $598,000 | +228.6% | 56,026 | +112.2% | 0.00% | +200.0% |
| Q4 2019 | $182,000 | +83.8% | 26,405 | +144.8% | 0.00% | – |
| Q1 2019 | $99,000 | +50.0% | 10,788 | +95.0% | 0.00% | – |
| Q3 2018 | $66,000 | -77.1% | 5,531 | -80.4% | 0.00% | -100.0% |
| Q2 2018 | $288,000 | +5660.0% | 28,233 | +7084.0% | 0.00% | – |
| Q1 2018 | $5,000 | – | 393 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 3,439,895 | $18,747,000 | 4.66% |
| Bain Capital Life Sciences Investors, LLC | 5,785,036 | $31,528,000 | 2.07% |
| Omega Fund Management, LLC | 2,274,831 | $12,398,000 | 1.40% |
| Altium Capital Management LP | 1,076,942 | $5,869,000 | 1.36% |
| Samsara BioCapital, LLC | 2,189,199 | $10,599,000 | 1.31% |
| Sio Capital Management, LLC | 800,000 | $4,360,000 | 1.08% |
| Flagship Pioneering Inc. | 2,938,494 | $16,015,000 | 0.20% |
| EcoR1 Capital, LLC | 1,000,000 | $5,450,000 | 0.20% |
| Artal Group S.A. | 1,700,000 | $9,265,000 | 0.19% |
| ACT CAPITAL MANAGEMENT, LLC | 52,500 | $287,000 | 0.15% |